Glycosylation  	Glycosylation  	 NNP	B-NP
of  	of  	 IN	I-NP
proteinase  	proteinase  	 CD	I-NP
3  	3  	 CD	O
( 	( 	 -LRB-	O
PR3 	PR3 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
not  	not  	 RB	O
required  	required  	 VBN	O
for  	for  	 IN	O
its  	its  	 PRP$	O
reactivity  	reactivity  	 NN	B-NP
with  	with  	 IN	O
antineutrophil  	antineutrophil  	 JJ	B-NP
cytoplasmic  	cytoplasmic  	 JJ	I-NP
antibodies  	antibodies  	 NNS	I-NP
( 	( 	 -LRB-	O
ANCA 	ANCA 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
Wegener 	Wegener 	 NNP	O
's  	's  	 POS	O
granulomatosis  	granulomatosis  	 VBG	O
The  	The  	 DT	O
glycosylation  	glycosylation  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
autoantigens  	autoantigens  	 NN	I-NP
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
crucial  	crucial  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	O
some  	some  	 DT	O
autoimmune  	autoimmune  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
since  	since  	 IN	O
carbohydrates  	carbohydrates  	 NNS	O
play  	play  	 VBP	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
distinction  	distinction  	 NN	O
of  	of  	 IN	O
self  	self  	 NN	O
from  	from  	 IN	O
non-self 	non-self 	 JJ	B-NP
.  	.  	 .	O
Proteinase  	Proteinase  	 NNP	B-NP
3  	3  	 CD	I-NP
( 	( 	 -LRB-	O
PR3 	PR3 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
main  	main  	 JJ	O
target  	target  	 NN	B-NP
antigen  	antigen  	 NN	I-NP
for  	for  	 IN	I-NP
anti-neutrophil  	anti-neutrophil  	 JJ	I-NP
cytoplasmic  	cytoplasmic  	 JJ	I-NP
antibodies  	antibodies  	 NNS	I-NP
( 	( 	 -LRB-	O
ANCA 	ANCA 	 NNP	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
Wegener 	Wegener 	 NNP	O
's  	's  	 POS	O
granulomatosis  	granulomatosis  	 NN	B-NP
( 	( 	 -LRB-	O
WG 	WG 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
contains  	contains  	 VBZ	O
two  	two  	 CD	O
Asn-linked  	Asn-linked  	 JJ	B-NP
glycosylation  	glycosylation  	 JJ	I-NP
sites 	sites 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
explores  	explores  	 VBZ	O
the  	the  	 DT	O
influence  	influence  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
glycosylation  	glycosylation  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
PR3  	PR3  	 CD	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
PR3  	PR3  	 JJ	B-NP
recognition  	recognition  	 NN	I-NP
by  	by  	 IN	O
ANCA  	ANCA  	 NNP	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
well  	well  	 RB	O
characterized  	characterized  	 VBN	B-NP
population  	population  	 NN	I-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
WG 	WG 	 NNP	B-NP
.  	.  	 .	O
Forty-four  	Forty-four  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
WG  	WG  	 NNP	B-NP
( 	( 	 -LRB-	O
459  	459  	 CD	O
serum  	serum  	 CD	O
samples 	samples 	 NNS	O
)  	)  	 -RRB-	O
who  	who  	 WP	O
participated  	participated  	 VBD	O
in  	in  	 IN	O
a  	a  	 DT	O
multicenter  	multicenter  	 JJ	B-NP
randomized  	randomized  	 JJ	I-NP
trial 	trial 	 NN	I-NP
,  	,  	 ,	O
were  	were  	 VBD	O
tested  	tested  	 VBN	O
by  	by  	 IN	O
capture  	capture  	 JJ	B-NP
ELISA  	ELISA  	 NN	I-NP
for  	for  	 IN	I-NP
ANCA  	ANCA  	 NNP	I-NP
against  	against  	 IN	O
PR3  	PR3  	 NNP	B-NP
and  	and  	 CC	O
deglycosylated  	deglycosylated  	 JJ	B-NP
recombinant  	recombinant  	 JJ	I-NP
variants  	variants  	 NN	I-NP
of  	of  	 IN	I-NP
PR3 	PR3 	 CD	I-NP
.  	.  	 .	O
The  	The  	 DT	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
followed  	followed  	 VBN	O
for  	for  	 IN	O
a  	a  	 DT	O
median  	median  	 NN	B-NP
of  	of  	 IN	O
27  	27  	 CD	O
months 	months 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
median  	median  	 JJ	B-NP
number  	number  	 NN	O
of  	of  	 IN	O
serum  	serum  	 JJ	O
samples  	samples  	 NNS	O
per  	per  	 IN	O
patient  	patient  	 NN	O
was  	was  	 VBD	O
10 	10 	 CD	O
.  	.  	 .	O
At  	At  	 IN	O
baseline 	baseline 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
ANCA  	ANCA  	 NNP	B-NP
against  	against  	 IN	O
PR3  	PR3  	 NNP	B-NP
and  	and  	 CC	O
against  	against  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
deglycosylated  	deglycosylated  	 JJ	B-NP
recombinant  	recombinant  	 JJ	I-NP
variants  	variants  	 NN	I-NP
of  	of  	 IN	I-NP
PR3  	PR3  	 NNP	I-NP
were  	were  	 VBD	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
0.94  	0.94  	 CD	O
( 	( 	 -LRB-	O
?  	?  	 NNP	O
< 	< 	 SYM	O
0.001  	0.001  	 NNP	O
for  	for  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
comparisons 	comparisons 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Longitudinal  	Longitudinal  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
comparing  	comparing  	 VBG	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
ANCA  	ANCA  	 NNP	B-NP
against  	against  	 IN	O
PR3  	PR3  	 CD	B-NP
versus  	versus  	 IN	O
all  	all  	 PDT	O
the  	the  	 DT	O
deglycosylated  	deglycosylated  	 JJ	B-NP
recombinant  	recombinant  	 JJ	I-NP
variants  	variants  	 NN	I-NP
of  	of  	 IN	I-NP
PR3 	PR3 	 NNP	I-NP
,  	,  	 ,	O
using  	using  	 VBG	O
linear  	linear  	 JJ	O
mixed  	mixed  	 JJ	O
models 	models 	 NNS	O
,  	,  	 ,	O
showed  	showed  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
statistical  	statistical  	 JJ	B-NP
differences  	differences  	 NNS	I-NP
( 	( 	 -LRB-	O
rho  	rho  	 CD	B-NP
> 	> 	 CD	O
or=0.90  	or=0.90  	 CD	O
in  	in  	 IN	O
all  	all  	 DT	O
cases 	cases 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
glycosylation  	glycosylation  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
PR3  	PR3  	 NNP	I-NP
has  	has  	 VBZ	O
no  	no  	 DT	O
impact  	impact  	 NN	O
on  	on  	 IN	O
its  	its  	 PRP$	O
recognition  	recognition  	 NN	O
by  	by  	 IN	O
ANCA  	ANCA  	 NNP	B-NP
in  	in  	 IN	O
WG 	WG 	 NNP	B-NP
.  	.  	 .	O
